{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:16:59Z","timestamp":1793049419522,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-07567-x","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T01:15:10Z","timestamp":1766798110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the use and efficacy of 5-fluorouracil in the management of odontogenic keratocysts: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Reema","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimrit","family":"Arbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clariel","family":"Ianculovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Peleg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"7567_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcms.2021.09.022","volume":"50","author":"P Boffano","year":"2022","unstructured":"Boffano P, Cavarra F, Agnone AM, et al. The epidemiology and management of odontogenic keratocysts (OKCs): A European multicenter study. J Craniomaxillofac Surg. 2022;50:1\u20136.","journal-title":"J Craniomaxillofac Surg"},{"key":"7567_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4103\/0976-9668.116968","volume":"4","author":"MT Nayak","year":"2013","unstructured":"Nayak MT, Singh A, Singhvi A, Sharma R. Odontogenic keratocyst: what is in the name? J Nat Sci Biol Med. 2013;4:282\u20135.","journal-title":"J Nat Sci Biol Med"},{"key":"7567_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12105-017-0794-1","volume":"11","author":"JM Wright","year":"2017","unstructured":"Wright JM, Vered M. Update from the 4th edition of the world health organization classification of head and neck tumours: odontogenic and maxillofacial bone tumors. Head Neck Pathol. 2017;11:68\u201377.","journal-title":"Head Neck Pathol"},{"key":"7567_CR4","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.ijom.2015.03.008","volume":"44","author":"MA Pogrel","year":"2015","unstructured":"Pogrel MA. The keratocystic odontogenic tumour (KCOT)--an odyssey. Int J Oral Maxillofac Surg. 2015;44:1565\u20138.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"7567_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.tripleo.2005.03.023","volume":"101","author":"D Chirapathomsakul","year":"2006","unstructured":"Chirapathomsakul D, Sastravaha P, Jansisyanont P. A review of odontogenic keratocysts and the behavior of recurrences. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:5\u201310.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"7567_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.coms.2012.11.003","volume":"25","author":"MA Pogrel","year":"2013","unstructured":"Pogrel MA. The keratocystic odontogenic tumor. Oral Maxillofac Surg Clin North Am. 2013;25:21\u2013v.","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"7567_CR7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.joms.2020.07.215","volume":"79","author":"MF Caminiti","year":"2021","unstructured":"Caminiti MF, El-Rabbany M, Jeon J, Bradley G. 5-Fluorouracil is associated with a decreased recurrence risk in odontogenic keratocyst management: A retrospective cohort study. J Oral Maxillofac Surg. 2021;79:814\u201321.","journal-title":"J Oral Maxillofac Surg"},{"key":"7567_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10006-022-01064-z","volume":"27","author":"FO Oginni","year":"2023","unstructured":"Oginni FO, Alasseri N, Ogundana OM, Famurewa BA, Pogrel A, Al-Moraissi EA. An evidence-based surgical algorithm for management of odontogenic keratocyst. Oral Maxillofac Surg. 2023;27:201\u201312.","journal-title":"Oral Maxillofac Surg"},{"key":"7567_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcms.2016.10.013","volume":"45","author":"EA Al-Moraissi","year":"2017","unstructured":"Al-Moraissi EA, Dahan AA, Alwadeai MS, et al. What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor? A large systematic review and meta-analysis. J Craniomaxillofac Surg. 2017;45:131\u201344.","journal-title":"J Craniomaxillofac Surg"},{"key":"7567_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bjoms.2023.04.006","volume":"61","author":"R Winters","year":"2023","unstructured":"Winters R, Garip M, Meeus J, Coropciuc R, Politis C. Safety and efficacy of adjunctive therapy in the treatment of odontogenic keratocyst: a systematic review. Br J Oral Maxillofac Surg. 2023;61:331\u20136.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"7567_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10006-024-01277-4","volume":"28","author":"TOF Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves TOF, Rangel RMR, Mara\u00f1\u00f3n-V\u00e1squez GA, et al. Management and recurrence of the odontogenic keratocyst: an overview of systematic reviews. Oral Maxillofac Surg. 2024;28:1457\u201378.","journal-title":"Oral Maxillofac Surg"},{"key":"7567_CR12","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.joms.2015.05.005","volume":"73","author":"JE Dashow","year":"2015","unstructured":"Dashow JE, McHugh JB, Braun TM, Edwards SP, Helman JI, Ward BB. Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using carnoy\u2019s versus modified carnoy\u2019s solution. J Oral Maxillofac Surg. 2015;73:2132\u20135.","journal-title":"J Oral Maxillofac Surg"},{"key":"7567_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s40001-024-01854-z","volume":"29","author":"M Dioguardi","year":"2024","unstructured":"Dioguardi M, Quarta C, Sovereto D, et al. Factors and management techniques in odontogenic keratocysts: a systematic review. Eur J Med Res. 2024;29:287.","journal-title":"Eur J Med Res"},{"key":"7567_CR14","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.joms.2016.09.039","volume":"75","author":"NJ Ledderhof","year":"2017","unstructured":"Ledderhof NJ, Caminiti MF, Bradley G, Lam DK. Topical 5-Fluorouracil is a novel targeted therapy for the keratocystic odontogenic tumor. J Oral Maxillofac Surg. 2017;75:514\u201324.","journal-title":"J Oral Maxillofac Surg"},{"key":"7567_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330\u20138.","journal-title":"Nat Rev Cancer"},{"key":"7567_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. Published 2021 Mar 29.","journal-title":"BMJ"},{"key":"7567_CR17","unstructured":"Wells GA, Shea B, O\u2019Connell D et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"7567_CR18","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"7567_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.51847\/exYxyn3qWB","volume":"11","author":"N Mishra","year":"2023","unstructured":"Mishra N, Dadhich A, Vande AV. Comparative evaluation of topical application of 5-fluorouracil and modified carnoy\u2019s solution in management of odontogenic keratocyst. Ann Dent Spec. 2023;11:99\u2013104.","journal-title":"Ann Dent Spec"},{"key":"7567_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jobcr.2023.03.007","volume":"13","author":"SA Wanve","year":"2023","unstructured":"Wanve SA, Andrade NN, Venkatakrishnan L, Desai H. Comparison of the effectiveness of 5-Fluorouracil and modified carnoy\u2019s solution in reducing the recurrence of odontogenic keratocyst. J Oral Biol Craniofac Res. 2023;13:436\u201341.","journal-title":"J Oral Biol Craniofac Res"},{"key":"7567_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jobcr.2020.07.008","volume":"10","author":"P Akhter Lone","year":"2020","unstructured":"Akhter Lone P, Ahmed Wani N, Ahmed Janbaz Z, Bibi M, Kour A. Topical 5-fluorouracil application in management of odontogenic keratocysts. J Oral Biol Craniofac Res. 2020;10:404\u20136.","journal-title":"J Oral Biol Craniofac Res"},{"key":"7567_CR22","doi-asserted-by":"publisher","first-page":"101558","DOI":"10.1016\/j.cpsurg.2024.101558","volume":"61","author":"MK Eid","year":"2024","unstructured":"Eid MK, Alqhtani NR, Atef AM, Sakka S. Application of topical 5-Fluorouracil to reduce the recurrence of odontogenic keratocyst: A prospective study with 2-year follow-up. Curr Probl Surg. 2024;61:101558.","journal-title":"Curr Probl Surg"},{"key":"7567_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/tdj.tdj_27_23","volume":"20","author":"E Essa","year":"2023","unstructured":"Essa E, Rafic R, Mohamed K. Efficacy of adjunct topical application of 5-Fluorouracil in reducing the recurrence of odontogenic keratocyst. Tanta Dent J. 2023;20:247\u201353.","journal-title":"Tanta Dent J"},{"key":"7567_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.joms.2022.09.010","volume":"81","author":"AJ Casino","year":"2023","unstructured":"Casino AJ, LeRoy J Jr, Reddy R, Lam DK. Refined topical 5-Fluorouracil technique for the targeted treatment of odontogenic keratocysts. J Oral Maxillofac Surg. 2023;81:95\u2013100.","journal-title":"J Oral Maxillofac Surg"},{"key":"7567_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.15386\/mpr-2067","volume":"96","author":"A Berberi","year":"2023","unstructured":"Berberi A, Aoun G, Hjeij B, Hosn MA. Combined Conservative treatment of a recurrent mandibular keratocyst by enucleation, diode laser, 5-Fluorouracil and dental implants: a case report with 18 years-follow up. Med Pharm Rep. 2023;96:106\u201310.","journal-title":"Med Pharm Rep"},{"key":"7567_CR26","first-page":"e44777","volume":"15","author":"CG Barua","year":"2023","unstructured":"Barua CG, Ali I, Tripathi A, Malakar A, Singha PK. The role of 5-Fluorouracil in preventing recurrence after enucleation of odontogenic keratocyst: A case report. Cureus. 2023;15:e44777.","journal-title":"Cureus"},{"key":"7567_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.29252\/jrdms.4.4.43","volume":"4","author":"H shiran","year":"2019","unstructured":"shiran H, Shafaei Fard S, Hakimi S, Azari Pour Esfahani A. Use of topical 5-Fluorouracil for keratocystic odontogenic tumors of Gorlin-Goltz syndrome as a new targeted therapy: A case report and review of literature. J Res Dent Maxillofac Sci. 2019;4:43\u20138.","journal-title":"J Res Dent Maxillofac Sci"},{"key":"7567_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.35366\/115901","volume":"4","author":"HCM Figueira","year":"2024","unstructured":"Figueira HCM, Villarroel DM, Hern\u00e1ndez A, Moret Y, Rosas NRV. Uso de 5-fluorouracilo En El Manejo Del queratoquiste odontog\u00e9nico. Reporte de Caso. Lat Am J Oral Maxillofac Surg. 2024;4:27\u201333.","journal-title":"Lat Am J Oral Maxillofac Surg"},{"key":"7567_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12663-022-01751-0","volume":"22","author":"P Banala","year":"2023","unstructured":"Banala P, Reddy GS, Harish Kumar TVS, Bhavani M. Antimetabolite in the management of odontogenic Keratocyst-A case report. J Maxillofac Oral Surg. 2023;22:132\u20135.","journal-title":"J Maxillofac Oral Surg"},{"key":"7567_CR30","first-page":"224","volume":"25","author":"\u00d3R Hern\u00e1ndez-Ortega","year":"2021","unstructured":"Hern\u00e1ndez-Ortega \u00d3R, Malanche-Abdal\u00e1 G, Salgado-Chavarr\u00eda F. Adjuvant therapy with topic 5-fluorouracil for odontogenic keratocyst, case report and literature review. Rev Odont Mex. 2021;25:224\u201332.","journal-title":"Rev Odont Mex"},{"key":"7567_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10006-022-01090-x","volume":"27","author":"LP Melean","year":"2023","unstructured":"Melean LP, Guerrero LM, Lopez L. 5-fluorouacil in the treatment of odontogenic keratocysts-incidence of recurrence and inferior alveolar nerve paresthesia: a systematic review. Oral Maxillofac Surg. 2023;27:489\u201396.","journal-title":"Oral Maxillofac Surg"},{"key":"7567_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcms.2016.11.010","volume":"45","author":"BR Chrcanovic","year":"2017","unstructured":"Chrcanovic BR, Gomez RS. Recurrence probability for keratocystic odontogenic tumors: an analysis of 6427 cases. J Craniomaxillofac Surg. 2017;45:244\u201351.","journal-title":"J Craniomaxillofac Surg"},{"key":"7567_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.oooo.2012.01.032","volume":"114","author":"F Titinchi","year":"2012","unstructured":"Titinchi F, Nortje CJ. Keratocystic odontogenic tumor: a recurrence analysis of clinical and radiographic parameters. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:136\u201342.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"7567_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40902-021-00301-x","volume":"43","author":"HD Jung","year":"2021","unstructured":"Jung HD, Lim JH, Kim HJ, Nam W, Cha IH. Appropriate follow-up period for odontogenic keratocyst: a retrospective study. Maxillofac Plast Reconstr Surg. 2021;43:16.","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"7567_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.oooo.2018.12.001","volume":"127","author":"B Kinard","year":"2019","unstructured":"Kinard B, Hansen G, Newman M, et al. How well do we manage the odontogenic keratocyst? A multicenter study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:282\u20138.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"7567_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/2050-6511-15-47","volume":"15","author":"A Polk","year":"2014","unstructured":"Polk A, Vistisen K, Vaage-Nilsen M, Nielsen DL. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacol Toxicol. 2014;15:47.","journal-title":"BMC Pharmacol Toxicol"},{"key":"7567_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/IOP.0000000000001532","volume":"36","author":"AD Bui","year":"2020","unstructured":"Bui AD, Grob SR, Tao JP. 5-Fluorouracil management of oculofacial scars: A systematic literature review. Ophthalmic Plast Reconstr Surg. 2020;36:222\u201330.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"7567_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1053\/j.seminoncol.2017.02.008","volume":"44","author":"M Boisdron-Celle","year":"2017","unstructured":"Boisdron-Celle M, Capitain O, Faroux R, et al. Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: assessment of a multiparametric approach. Semin Oncol. 2017;44:13\u201323.","journal-title":"Semin Oncol"},{"key":"7567_CR39","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bjoms.2022.02.001","volume":"60","author":"AK Singh","year":"2022","unstructured":"Singh AK, Khanal N, Chaulagain R, Bhujel N, Singh RP. How effective is 5-Fluorouracil as an adjuvant in the management of odontogenic keratocyst? A systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2022;60:746\u201354.","journal-title":"Br J Oral Maxillofac Surg"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-07567-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-07567-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-07567-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:38:48Z","timestamp":1769603928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-025-07567-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7567"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-07567-x","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}